14-day Premium Trial Subscription Try For FreeTry Free
RBC Capital analyst Frank Morgan maintained a Buy rating on Select Medical (SEM) today and set a price target of $26.00. The company's shares closed last
RBC Capital analyst Frank Morgan maintained a Buy rating on Select Medical ( SEM – Research Report ) today and set a price target of $26.00 . The company’s shares closed last Monday at $16.00. Acc
In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Pennant Group (PNTG), with a price target of $26.00. The company's
In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Pennant Group ( PNTG – Research Report ), with a price target of $26.00 . The company’s shares closed last Fri
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Acadia Healthcare (ACHC), with a price target of $34.00. The
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Acadia Healthcare (ACHC – Research
In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Fresenius Medical Care (FMS), with a price target of $42.00. The
In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Fresenius Medical Care ( FMS – Research Report ), with a price target of $42.00 . The company’s shares closed
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on The Ensign Group (ENSG), with a price target of $48.00. The company's
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on The Ensign Group ( ENSG – Research Report ), with a price target of $48.00 . The company’s shares closed last M
RBC Capital analyst Frank Morgan maintained a Hold rating on DaVita (DVA) today and set a price target of $75.00. The company's shares closed last Monday
RBC Capital analyst Frank Morgan maintained a Hold rating on DaVita ( DVA – Research Report ) today and set a price target of $75.00 . The company’s shares closed last Monday at $77.20. According
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Encompass Health (EHC), with a price target of $84.00. The company's
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Encompass Health ( EHC – Research Report ), with a price target of $84.00 . The company’s shares closed last Mo
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Addus Homecare (ADUS), with a price target of $98.00. The company's
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE